Literature DB >> 10496942

Role of gamma interferon in controlling murine chlamydial genital tract infection.

J I Ito1, J M Lyons.   

Abstract

Earlier investigations have not shown an important role for gamma interferon (IFN-gamma) in the early clearance of chlamydial infection from the murine female genital tract. In a model using a human genital isolate of Chlamydia trachomatis in IFN-gamma and IFN-gamma receptor knockout mice, we were able to demonstrate a major role for IFN-gamma in mediating control of infection throughout the course of infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10496942      PMCID: PMC96917          DOI: 10.1128/IAI.67.10.5518-5521.1999

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  10 in total

1.  AN UNIDENTIFIED VIRUS WHICH PRODUCES PNEUMONIA AND SYSTEMIC INFECTION IN MICE.

Authors:  C Nigg
Journal:  Science       Date:  1942-01-09       Impact factor: 47.728

2.  Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in gamma interferon receptor-deficient mice despite a strong local immunoglobulin A response.

Authors:  M Johansson; K Schön; M Ward; N Lycke
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

3.  Variation in virulence among oculogenital serovars of Chlamydia trachomatis in experimental genital tract infection.

Authors:  J I Ito; J M Lyons; L P Airo-Brown
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

4.  Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice.

Authors:  T W Cotter; K H Ramsey; G S Miranpuri; C E Poulsen; G I Byrne
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

5.  Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways.

Authors:  L L Perry; K Feilzer; H D Caldwell
Journal:  J Immunol       Date:  1997-04-01       Impact factor: 5.422

6.  Lymphokine-mediated inhibition of Chlamydia replication in mouse fibroblasts is neutralized by anti-gamma interferon immunoglobulin.

Authors:  G I Byrne; D A Krueger
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

7.  Establishment of genital tract infection in the CF-1 mouse by intravaginal inoculation of a human oculogenital isolate of Chlamydia trachomatis.

Authors:  J I Ito; H R Harrison; E R Alexander; L J Billings
Journal:  J Infect Dis       Date:  1984-10       Impact factor: 5.226

8.  Effect of gamma interferon on resolution of murine chlamydial genital infection.

Authors:  R G Rank; K H Ramsey; E A Pack; D M Williams
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

9.  Long-term effects of gamma interferon on chlamydia-infected host cells: microbicidal activity follows microbistasis.

Authors:  G I Byrne; J M Carlin; T P Merkert; D L Arter
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

10.  Pneumonia due to Chlamydia trachomatis in the immunocompromised (nude) mouse.

Authors:  D M Williams; J Schachter; D J Drutz; C V Sumaya
Journal:  J Infect Dis       Date:  1981-02       Impact factor: 5.226

  10 in total
  36 in total

Review 1.  Immunity to murine chlamydial genital infection.

Authors:  Richard P Morrison; Harlan D Caldwell
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

2.  Differential sensitivities of Chlamydia trachomatis strains to inhibitory effects of gamma interferon.

Authors:  R P Morrison
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 3.  Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model.

Authors:  Christina M Farris; Richard P Morrison
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

4.  Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.

Authors:  Ashlesh K Murthy; James P Chambers; Patricia A Meier; Guangming Zhong; Bernard P Arulanandam
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

5.  Chlamydia-specific CD4 T cell clones control Chlamydia muridarum replication in epithelial cells by nitric oxide-dependent and -independent mechanisms.

Authors:  Krupakar Jayarapu; Micah Kerr; Susan Ofner; Raymond M Johnson
Journal:  J Immunol       Date:  2010-10-29       Impact factor: 5.422

6.  T cell responses in the absence of IFN-gamma exacerbate uterine infection with Chlamydia trachomatis.

Authors:  David C Gondek; Nadia R Roan; Michael N Starnbach
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

7.  Murine models of Chlamydia trachomatis genital tract infection: use of mouse pneumonitis strain versus human strains.

Authors:  S A Morré; J M Lyons; J I Ito
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

8.  Differences in growth characteristics and elementary body associated cytotoxicity between Chlamydia trachomatis oculogenital serovars D and H and Chlamydia muridarum.

Authors:  J M Lyons; J I Ito; A S Peña; S A Morré
Journal:  J Clin Pathol       Date:  2005-04       Impact factor: 3.411

9.  A limited role for antibody in protective immunity induced by rCPAF and CpG vaccination against primary genital Chlamydia muridarum challenge.

Authors:  Ashlesh K Murthy; Bharat K R Chaganty; Weidang Li; M Neal Guentzel; James P Chambers; J Seshu; Guangming Zhong; Bernard P Arulanandam
Journal:  FEMS Immunol Med Microbiol       Date:  2009-03

10.  Caspase-1 contributes to Chlamydia trachomatis-induced upper urogenital tract inflammatory pathologies without affecting the course of infection.

Authors:  Wen Cheng; Pooja Shivshankar; Zhongyu Li; Lili Chen; I-Tien Yeh; Guangming Zhong
Journal:  Infect Immun       Date:  2007-11-19       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.